Literature DB >> 6329907

A complete set of overlapping cosmid clones of M-ABA virus derived from nasopharyngeal carcinoma and its similarity to other Epstein-Barr virus isolates.

A Polack, G Hartl, U Zimber, U K Freese, G Laux, K Takaki, B Hohn, L Gissmann, G W Bornkamm.   

Abstract

DNA of the transforming, nondefective Epstein-Barr virus (EBV) strain M-ABA, which is derived from nasopharyngeal carcinoma cells, was cloned as large overlapping pieces into the cosmid pHC79 . The termini were cloned from closed circular virus DNA molecules out of M-ABA cell DNA in phage lambda L47 . The large overlapping clones were used to prepare a library of subclones with inserts of 1-15 kb. A detailed restriction enzyme map of M-ABA virus DNA reveals the close similarity to isolates from other sources. The high number of tandem repeats in EBV DNA stresses the importance of using cloning vectors that can be propagated in recA- Escherichia coli hosts.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6329907     DOI： 10.1016/0378-1119(84)90072-6

Source DB:  PubMed          Journal:  Gene        ISSN： 0378-1119            Impact factor:   3.688


  50 in total

1.  Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.

Authors:  A Staratschek-Jox; S Kotkowski; G Belge; T Rüdiger; J Bullerdiek; V Diehl; J Wolf
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

2.  Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas.

Authors:  G Niedobitek; L S Young; C K Sam; L Brooks; U Prasad; A B Rickinson
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

3.  Lytic cycle gene regulation of Epstein-Barr virus.

Authors:  Wolfgang Amon; Ulrich K Binné; Helen Bryant; Peter J Jenkins; Claudio Elgueta Karstegl; Paul J Farrell
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

4.  Biochemical characterization of Epstein-Barr virus nuclear antigen 2A.

Authors:  F A Grässer; P Haiss; S Göttel; N Mueller-Lantzsch
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

5.  Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.

Authors:  U Zimber-Strobl; K O Suentzenich; G Laux; D Eick; M Cordier; A Calender; M Billaud; G M Lenoir; G W Bornkamm
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

6.  The latent origin of replication of Epstein-Barr virus directs viral genomes to active regions of the nucleus.

Authors:  Manuel J Deutsch; Elisabeth Ott; Peer Papior; Aloys Schepers
Journal:  J Virol       Date:  2009-12-23       Impact factor: 5.103

7.  Intron retention may regulate expression of Epstein-Barr virus nuclear antigen 3 family genes.

Authors:  N Kienzle; D B Young; D Liaskou; M Buck; S Greco; T B Sculley
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

8.  Identification and characterization of an Epstein-Barr virus early antigen that is encoded by the NotI repeats.

Authors:  C M Nuebling; N Mueller-Lantzsch
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

9.  Immortalization of human primary B lymphocytes in vitro with DNA.

Authors:  B Kempkes; D Pich; R Zeidler; W Hammerschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

10.  AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization.

Authors:  S J Hamilton-Dutoit; G Pallesen; M B Franzmann; J Karkov; F Black; P Skinhøj; C Pedersen
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.